| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0005 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0007 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0008 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |